FDA Adverse Event Malfunction Summary report: N

BD OMNITROPE® PEN 10

MDR report key: 9244801 · Received October 28, 2019

Report

Report Number
2243072-2019-02389
Event Type
Malfunction
Date Received
October 28, 2019
Date of Event
October 10, 2019
Report Date
October 30, 2019
Manufacturer
BECTON DICKINSON
Product Code
FMI
PMA / PMN Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AU
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION SUMMARY: ONE (1) SAMPLE WAS PROVIDED TO BD MEDICAL ¿ PHARMACEUTICAL SYSTEM (BDM-PS) FOR ANALYSIS. BDM-PS PERFORMED A BATCH HISTORY RECORD¿S REVIEW (BHR) INCLUDING A REVIEW OF ALL DATA COLLECTED DURING IN PROCESS AND QUALITY INSPECTIONS. THE BATCH INVOLVED IN THIS COMPLAINT MEETS ALL ACCEPTABLE QUALITY LEVELS (AQL¿S), WAS MANUFACTURED AND RELEASED ACCORDING TO APPLICABLE PROCEDURES AND SPECIFICATIONS. INITIAL EVALUATION OF THE COMPLAINT SAMPLE REVEALED A CRACKED AND BROKEN VIAL RETAINER. THE ROOT CAUSE OF THE BROKEN VIAL RETAINER IS MOST LIKELY MATERIAL INCOMPATIBILITY. BREAKING FROM MATERIAL INCOMPATIBILITY IS DUE TO THE INTERACTION BETWEEN THE POLYCARBONATE OF THE VIAL RETAINER COMPONENT AND DIOCTYL PHTHALATE FOUND IN THE PEN POUCH. CHEMICAL COMPATIBILITY OVERVIEW FOR LEXAN POLYCARBONATE RECOMMENDS AGAINST THE USE OF DIOCYTL PHTHALATE IN CONJUNCTION WITH POLYCARBONATE AS IT RESULTS IN FAILURE OR SEVERE DEGRADATION. CORRECTIVE ACTIONS HAVE BEEN DETERMINED TO INFORM SANDOZ GMBH OF MATERIAL COMPATIBILITY WITH THE PEN POUCH. PREVENTATIVE ACTION HAS BEEN ESTABLISHED FOR SANDOZ TO UPDATE THE PEN POUCH MATERIAL. BASED ON ANALYSIS AND STUDIES THAT HAVE BEEN SUMMARIZED IN ¿SANDOZ OMNITROPE® PEN 5 & OMNITROPE® PEN 10 PEN CRACK ROOT CAUSE INVESTIGATION¿ (DATED (B)(6) 2016) ONE POTENTIAL ROOT CAUSE HAS BEEN IDENTIFIED. 1.BREAKING ON THE VIAL RETAINER FROM MATERIAL INCOMPATIBILITY IS DUE TO THE INTERACTION BETWEEN THE POLYCARBONATE OF THE PEN COMPONENTS AND DIOCTYL PHTHALATE FOUND IN THE PEN POUCH. SANDOZ HAS BEEN INFORMED OF THE MATERIAL COMPATIBILITY ISSUE BY BD. SANDOZ HAS INFORMED BD THAT THE POUCH WILL BE UPDATED BY MIDDLE OF 2019. H3 OTHER TEXT : SEE SECTION H.10.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE BD OMNITROPE® PEN 10 WAS FOUND CRACKED BETWEEN THE AMPOULE HOLDER AND THE BODY BEFORE USE. THE DEFECT WAS FOUND WHEN THE CONSUMER WENT TO PULL THE "2MG" DOSE OF MEDICATION FROM THE REFRIGERATOR. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE CUSTOMER INFORMED THAT USE 2MG EVERYDAY AND INFORMED THAT THE PEN APPEARED CRACKED, THE SON WENT TO GET THE MEDICATION FROM THE REFRIGERATOR AND WHEN HE SAW THE PEN WAS CRACKED BETWEEN THE AMPOULE HOLDER AND THE BODY OF THE PEN, CAN NOT TELL IF IT WAS MISHANDLING OR THE PEN BROKE."

Additional Manufacturer Narrative · 1

OEM MANUFACTURER: THE MANUFACTURING LOCATION FOR THIS PRODUCT IS (B)(4). THIS SITE IS AN OEM MANUFACTURING SITE. THEREFORE, BD CORPORATE HEADQUARTERS IN (B)(4) HAS BEEN LISTED AND THE (B)(4) FDA REGISTRATION NUMBER HAS BEEN USED FOR THE MANUFACTURE REPORT NUMBER. DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. (B)(6). A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE BD OMNITROPE® PEN 10 WAS FOUND CRACKED BETWEEN THE AMPOULE HOLDER AND THE BODY BEFORE USE. THE DEFECT WAS FOUND WHEN THE CONSUMER WENT TO PULL THE "2MG" DOSE OF MEDICATION FROM THE REFRIGERATOR. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: "THE CUSTOMER INFORMED THAT USE 2MG EVERYDAY AND INFORMED THAT THE PEN APPEARED CRACKED, THE SON WENT TO GET THE MEDICATION FROM THE REFRIGERATOR AND WHEN HE SAW THE PEN WAS CRACKED BETWEEN THE AMPOULE HOLDER AND THE BODY OF THE PEN, CAN NOT TELL IF IT WAS MISHANDLING OR THE PEN BROKE."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1042436 BD OMNITROPE® PEN 10 PEN NEEDLE FMI BECTON DICKINSON 20120235

Patients

Seq Age Sex Outcome Treatment
1 Other